F Bissonnette

No ORCID on file · 5 papers in corpus
observational 2020
CARTR Plus: the creation of an ART registry in Canada
Human reproduction open ·doi:10.1093/hropen/hoaa022

STUDY QUESTION: What is the status of fertility treatment and birth outcomes documented over the first 6 years of the Canadian Assisted Reproductive Technologies Register (CARTR) Plus registry? SUMMARY ANSWER: The CARTR Plus registry is a …

2009
Levonorgestrel intrauterine system and medroxyprogesterone acetate for treatment of heavy menstrual bleeding
·doi:10.1016/j.contraception.2009.05.069
other 1998
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues
Journal of assisted reproduction and genetics ·doi:10.1023/a:1020381310860

PURPOSE: Our purpose was to assess the effect of pretreatment with oral contraceptives (OCs) on the formation of functional ovarian cysts during pituitary suppression with gonadotropin-releasing hormone (GnRH) agonists, subsequent follicula…

other 1998
Results of laparoscopic treatments of ovarian endometriomas: laparoscopic ovarian fenestration and coagulation
Fertility and sterility ·doi:10.1016/s0015-0282(98)00219-2

OBJECTIVE: To determine the long-term results of laparoscopic fenestration and coagulation of ovarian endometriomas and to compare them with the results of ovarian cystectomy performed by either laparotomy or laparoscopy. DESIGN: Case-cont…

observational 1992
Substance P in peritoneal fluid
American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(92)91852-2

Substance P is a neuropeptide that has been identified in the ovary, fallopian tube, uterus, and vagina and in the hypothalamic-pituitary axis in both an animal model and human ovaries. We sought to determine if substance P is present in pe…